Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

EU approves Wayrilz (rilzabrutinib) as the first BTK inhibitor to treat immune thrombocytopenia – Sanofi

Written by | 14 Jan 2026

The European Commission has approved Wayrilz (rilzabrutinib), a novel, oral, reversible, Bruton’s tyrosine kinase (BTK) inhibitor, as a new treatment for immune thrombocytopenia (ITP) in adult patients who… read more.

One in 14 patients having day case surgery have new or worse chronic pain 3 months after their operation

Written by | 13 Jan 2026

Two new studies published in Anaesthesia (the journal of the Association of Anaesthetists) analysing pain and other factors connected with day surgery in the UK show that around 1 in… read more.

Ben-Gurion University chemists develop smart plastic-like materials that use light or gentle heat to activate

Written by | 13 Jan 2026

Chemists at Ben-Gurion University of the Negev have developed a “smart” polymer that could make industrial curing, 3D printing and repairs simpler, safer and more energy-efficient with materials… read more.

FDA approval for Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction long term and to reduce the risk of major adverse CV events – Novo Nordisk

Written by | 13 Jan 2026

Novo Nordisk  announced that the FDA has approved the Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction long term and… read more.

Microbes in breast milk help populate infant gut microbiomes

Written by | 12 Jan 2026

Most conversations about breast milk tend to focus on topics like nutrients, antibodies and bonding time rather than bacteria. But it turns out that human milk carries its… read more.

1.6 million UK adults used weight loss drugs in past year

Written by | 12 Jan 2026

An estimated 1.6 million adults in England, Wales and Scotland used drugs such as Wegovy and Mounjaro to help lose weight between early 2024 and early 2025, according… read more.

Orexo enters into agreement with Dexcel Pharma to divest US Rights to Zubsolv (buprenorphine/naloxone)

Written by | 12 Jan 2026

Orexo AB announced the signing of an agreement with Dexcel Pharma to divest the full US  rights to Zubsolv (buprenorphine/naloxone) sublingual tablet CIII, for the treatment of opioid… read more.

Exercise to treat depression yields similar results to therapy

Written by | 11 Jan 2026

Exercise may reduce symptoms of depression to a similar extent as psychological therapy, according to an updated Cochrane review. When compared with antidepressant medication, exercise also showed a similar effect,… read more.

Cardiovascular risk score predicts multiple eye diseases

Written by | 11 Jan 2026

A new study from UCLA Health shows that a cardiovascular risk score already used routinely in primary care can predict who will develop serious eye diseases years later…. read more.

Daridorexant investigated in women during menopausal transition age with insomnia – Idorsia

Written by | 11 Jan 2026

Idorsia announced the publication of “Efficacy and safety of daridorexant for the treatment of insomnia disorder in women during menopausal transition age: Insights from a randomized controlled trial”… read more.

Back pain linked to worse sleep years later in men over 65, according to study

Written by | 10 Jan 2026

About half of older men suffer from sleep problems, back pain or both, according to Soomi Lee, associate professor of human development and family studies at Penn State. Lee recently led a study to… read more.

New light-triggered microneedle patch could make IVF hormone delivery painless and automated

Written by | 10 Jan 2026

A McGill University research team has developed a painless, automated way to deliver in vitro fertilization (IVF) hormones using a light-activated microneedle patch, an innovation that could ease… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.